{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:21:12Z","timestamp":1788751272896,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00432-022-04033-x","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:23:14Z","timestamp":1652790194000},"page":"1541-1549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["All EGFR mutations are (not) created equal: focus on uncommon EGFR mutations"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-9824","authenticated-orcid":false,"given":"Batra","family":"Ullas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathany","family":"Shrinidhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharma","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jain","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanda","family":"Surender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose T.","family":"Joslia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehta","family":"Anurag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"issue":"suppl 8","key":"4033_CR1","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/annonc\/mdy424","volume":"29","author":"A Brindel","year":"2018","unstructured":"Brindel A, Althakfi W, Barritault M et al (2018) Uncommon EGFR mutations in lung adenocarcinomas: clinical features and response to tyrosine kinase inhibitors. Ann Oncol 29(suppl 8):2017\u20132018. https:\/\/doi.org\/10.1093\/annonc\/mdy424","journal-title":"Ann Oncol"},{"key":"4033_CR2","doi-asserted-by":"crossref","unstructured":"Chakravarty D, Gao J, Phillips S et al (2017) OncoKB: a precision oncology knowledge base. JCO Precis Oncol. (1):1\u201316. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf","DOI":"10.1200\/PO.17.00011"},{"issue":"5","key":"4033_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/JTO.0000000000000504","volume":"10","author":"C-H Chiu","year":"2015","unstructured":"Chiu C-H et al (2015) Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced lung adenocarcinomas. J Thorac Oncol 10(5):793\u2013799. https:\/\/doi.org\/10.1097\/JTO.0000000000000504","journal-title":"J Thorac Oncol"},{"key":"4033_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/LCTT.S181406","volume":"10","author":"S Kate","year":"2019","unstructured":"Kate S, Chougule A, Joshi A et al (2019) Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. Lung Cancer Targets Ther 10:1\u201310","journal-title":"Lung Cancer Targets Ther"},{"issue":"11","key":"4033_CR5","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35(11):1978\u20131980. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897","journal-title":"Bioinformatics"},{"key":"4033_CR6","unstructured":"Kusnoor SV, Koonce TY, Levy MA, et al (2016) My cancer genome: evaluating an educational model to introduce patients and caregivers to precision medicine information. In: AMIA Jt Summits Transl Sci Proceedings. 2016:112\u2013121. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27570660%0A; http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC5001739"},{"issue":"D1","key":"4033_CR7","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M et al (2018) ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46(D1):D1062\u2013D1067. https:\/\/doi.org\/10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"4033_CR8","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1002\/cncr.29493.EGFR","volume":"121","author":"J Naidoo","year":"2016","unstructured":"Naidoo J, Rodriguez K, Busby N, Nafa K, Ladanyi M (2016) EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib. J Cancer 121(18):3212\u20133220. https:\/\/doi.org\/10.1002\/cncr.29493.EGFR","journal-title":"J Cancer"},{"key":"4033_CR9","unstructured":"Network NCC. Non-small cell lung cancer (Version3.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Published 2020. Accessed 10 Apr 2020"},{"issue":"2","key":"4033_CR10","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1016\/j.cllc.2018.11.005","volume":"20","author":"A Passaro","year":"2019","unstructured":"Passaro A, Prelaj A, Bonanno L et al (2019) Activity of EGFR TKIs in caucasian patients with NSCLC harboring potentially sensitive uncommon EGFR mutations. Clin Lung Cancer 20(2):e186\u2013e194. https:\/\/doi.org\/10.1016\/j.cllc.2018.11.005","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"4033_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12325-019-00903-y","volume":"36","author":"K Prabhash","year":"2019","unstructured":"Prabhash K, Advani SH, Batra U et al (2019) Biomarkers in non-small cell lung cancers: Indian Consensus Guidelines for molecular testing. Adv Ther 36(4):766\u2013785. https:\/\/doi.org\/10.1007\/s12325-019-00903-y","journal-title":"Adv Ther"},{"issue":"5","key":"4033_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30.Standards","volume":"17","author":"LS Richards","year":"2015","unstructured":"Richards LS, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Sue. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30.Standards","journal-title":"Genet Med"},{"issue":"3","key":"4033_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.lungcan.2007.06.024","volume":"58","author":"H Sasaki","year":"2007","unstructured":"Sasaki H, Endo K, Takada M et al (2007) EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer 58(3):324\u2013328","journal-title":"Lung Cancer"},{"key":"4033_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081.RECIST","author":"LH Schwartz","year":"2017","unstructured":"Schwartz LH, Liti\u00e8re S, Vries E et al (2017) RECIST 1.1\u2014update and clarification: from the RECIST Committee. Eur J Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081.RECIST","journal-title":"Eur J Cancer"},{"issue":"139","key":"4033_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2019.10.030","volume":"2020","author":"AC Sousa","year":"2019","unstructured":"Sousa AC, Silveira C, Janeiro A et al (2019) Detection of rare and novel EGFR mutations in NSCLC patients: implications for treatment-decision. Lung Cancer 2020(139):35\u201340. https:\/\/doi.org\/10.1016\/j.lungcan.2019.10.030","journal-title":"Lung Cancer"},{"issue":"D1","key":"4033_CR16","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC et al (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47(D1):D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gky1015","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4033_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG et al (2015) The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10(9):1243\u20131260. https:\/\/doi.org\/10.1097\/JTO.0000000000000630","journal-title":"J Thorac Oncol"},{"issue":"November","key":"4033_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.lungcan.2017.11.005","volume":"114","author":"H Tu","year":"2017","unstructured":"Tu H, Ke E, Yang J et al (2017) A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer. Lung Cancer 114(November):96\u2013102. https:\/\/doi.org\/10.1016\/j.lungcan.2017.11.005","journal-title":"Lung Cancer"},{"key":"4033_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0038-9","author":"S Vyse","year":"2019","unstructured":"Vyse S (2019) Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-019-0038-9","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"4033_CR20","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-10-3408","volume":"17","author":"JY Wu","year":"2011","unstructured":"Wu JY, Yu CJ, Chang YC, Yang CH, Shih JY, Yang PC (2011) Effectiveness of tyrosine kinase inhibitors on \u201cuncommon\u201d epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer. Clin Cancer Res 17(11):3812\u20133821. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3408","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4033_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1470-2045(15)00026-1","volume":"16","author":"JCH Yang","year":"2015","unstructured":"Yang JCH, Sequist LV, Mok TS, Schuler M (2015) Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Lancet Oncol 16(7):830\u2013838","journal-title":"Lancet Oncol"},{"key":"4033_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.11.018","author":"S Yang","year":"2019","unstructured":"Yang S, Mao S, Li X et al (2019) Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC. Lung Cancer. https:\/\/doi.org\/10.1016\/j.lungcan.2019.11.018","journal-title":"Lung Cancer"},{"issue":"5","key":"4033_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jtho.2019.12.126","volume":"15","author":"JC Yang","year":"2020","unstructured":"Yang JC, Schuler M, Popat S et al (2020) Afatinib for the treatment of NSCLC harboring uncommon EGFR mutations: a database of 693 cases. J Thorac Oncol 15(5):803\u2013815. https:\/\/doi.org\/10.1016\/j.jtho.2019.12.126","journal-title":"J Thorac Oncol"},{"key":"4033_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007205.Structural","author":"H Yasuda","year":"2014","unstructured":"Yasuda H, Park E, Yun C-H et al (2014) Structural, biochemical and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3007205.Structural","journal-title":"Sci Transl Med."},{"key":"4033_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0116","author":"J Yun","year":"2020","unstructured":"Yun J, Lee S, Kim S et al (2020) Antitumor activity of amivantamab ( JNJ-61186372), an EGFR\u2014MET bispecific antibody, in diverse models of EGFR Exon 20 insertion\u2014driven NSCLC. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0116","journal-title":"Cancer Discov"},{"issue":"3","key":"4033_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.21037\/tlcr.2019.04.12","volume":"8","author":"T Zhang","year":"2019","unstructured":"Zhang T, Wan B, Zhao Y et al (2019) Treatment of uncommon EGFR mutations in non-small cell lung cancer\u202f: new evidence and treatment. Transl Lung Cancer Res 8(3):302\u2013316. https:\/\/doi.org\/10.21037\/tlcr.2019.04.12","journal-title":"Transl Lung Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04033-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:01:13Z","timestamp":1679860873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4033"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04033-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript has been reviewed and approved by the Rajiv Gandhi Cancer Institute and Research Centre Institutional Ethics Committee and Review Board (approval no. Res\/SCM\/41\/2020\/107).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}